- Home
- DOMH vs NTRB Comparison
DOMH vs NTRB Comparison
Compare DOMH & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOMH | NTRB |
|---|---|---|
| Founded | 1967 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 69.2M | 57.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DOMH | NTRB |
|---|---|---|
| Price | $4.32 | $4.39 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | ★ 243.3K | 61.4K |
| Earning Date | 11-10-2025 | 12-11-2025 |
| Dividend Yield | ★ 15.99% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 9.19 | N/A |
| Revenue | ★ $99,588,000.00 | $2,278,321.00 |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | N/A | $3,394.36 |
| P/E Ratio | $0.45 | ★ N/A |
| Revenue Growth | ★ 691.07 | 12.69 |
| 52 Week Low | $1.03 | $3.90 |
| 52 Week High | $13.58 | $11.78 |
Technical Indicators
Market Signals| Indicator | DOMH | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 46.52 | 45.33 |
| Support Level | $4.16 | $4.17 |
| Resistance Level | $4.65 | $4.49 |
| Average True Range (ATR) | 0.27 | 0.34 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 18.95 | 12.50 |
Price Performance
Historical ComparisonAbout DOMH Dominari Holdings Inc.
Dominari Holdings Inc through its various subsidiaries, is currently engaged in wealth management, investment banking, securities sales and trading and asset management. The company operates in two reportable business segments: Dominari Financial and Legacy AIkido. The Dominari Financial reportable business segment represents the Company's broker-dealer business, which is composed of mostly underwriting and transactional service activities. The Legacy AIkido reportable business segment includes Aikido Labs, which manages the investments holdings of the legacy entity. It generates the majority of its revenue from the Dominari Financial segment.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.